Ramsay Health Care Ltd (ASX: RHC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ramsay Health Care Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $12.56 billion
P/E Ratio 39.51
Dividend Yield 1.70%
Shares Outstanding 230.83 million
Earnings per share 1.358
Dividend per share 0.97
Year To Date Return 58.79%
Earnings Yield 2.53%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Ramsay Health Care Ltd (ASX: RHC)
    Latest News

    a woman
    ⏸️ Investing

    3 winning stocks for a Race Day portfolio

    A losing punt on the horses means less money available for investing in quality stocks such as Coca-Cola Amatil Ltd…

    Read more »

    ⏸️ Investing

    Top stock picks for November

    Trade Me Group Ltd (ASX:TME) and Qube Holdings Ltd (ASX:QUB) are amongst the best picks for this month.

    Read more »

    a woman
    ⏸️ Investing

    3 stocks to buy and hold for 10 years: Woodside Petroleum Limited, Fortescue Metals Group Limited and Ramsay Health Care Limited

    These 3 stocks could deliver superb long term gains: Woodside Petroleum Limited (ASX:WPL), Fortescue Metals Group Limited (ASX:FMG) and Ramsay…

    Read more »

    ⏸️ Investing

    5 things you need to know about the Australian sharemarket today

    Crash alert on ASX following a volatile day on offshore markets

    Read more »

    a woman
    ⏸️ Investing

    Beat the ASX with these 3 stocks: Westpac Banking Corp, Fortescue Metals Group Limited and Ramsay Health Care Limited

    Outperforming the ASX could prove to be an easier task with Westpac Banking Corp (ASX:WBC), Fortescue Metals Group Limited (ASX:FMG)…

    Read more »

    a woman
    ⏸️ Investing

    3 growth stocks to power your portfolio

    Invest the Warren Buffett Way for the long term with companies like Ramsay Health Care Limited (ASX:RHC), REA Group Limited…

    Read more »

    a woman
    ⏸️ Investing

    2 top stocks you need to know

    Ramsay Health Care Limited (ASX:RHC) and REA Group Limited (ASX:REA) both have exciting opportunities to grow profits.

    Read more »

    ⏸️ Investing

    Do you own these 3 large-cap growth stocks?

    These 3 large-cap growth stocks could be worth buying: QBE Insurance Group Ltd (ASX:QBE), AMP Limited (ASX:AMP) and Ramsay Health…

    Read more »

    a woman
    ⏸️ Investing

    Could these 4 stocks help fund your retirement?

    A legendary investor once only bought companies that he knew intimately, maybe you should too.

    Read more »

    ⏸️ Investing

    4 stocks you'd love to buy but probably shouldn't

    High P/E stocks can disappoint and be slammed by the market, but that doesn't mean I haven't got my eye…

    Read more »

    ⏸️ Investing

    Do you own these 12 blue chip growth stocks?

    You could have made a 34% return with these companies.

    Read more »

    ⏸️ Investing

    3 reasons to buy CSL Limited

    Here’s why you should add CSL Limited (ASX:CSL) and Ramsay Health Care Limited (ASX:RHC) to your portfolio.

    Read more »

    Frequently Asked Questions

    Yes, Ramsay Health Care has historically paid two fully franked dividends a year.

    Ramsay Health Care generally pays its shareholder dividends in March and September. 

    Ramsay Health Care Ltd listed on the ASX on 24 September 1997.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    03 Sep 2026 $0.4850 100.00% Final 24 Sep 2026
    09 Mar 2026 $0.4250 100.00% Interim 26 Mar 2026
    03 Sep 2025 $0.4000 100.00% Final 25 Sep 2025
    06 Mar 2025 $0.4000 100.00% Interim 27 Mar 2025
    04 Sep 2024 $0.4000 100.00% Final 26 Sep 2024
    11 Mar 2024 $0.4000 100.00% Interim 05 Apr 2024
    06 Sep 2023 $0.2500 100.00% Final 29 Sep 2023
    06 Mar 2023 $0.5000 100.00% Interim 30 Mar 2023
    05 Sep 2022 $0.4850 100.00% Final 29 Sep 2022
    07 Mar 2022 $0.4850 100.00% Interim 31 Mar 2022
    06 Sep 2021 $1.0300 100.00% Final 30 Sep 2021
    08 Mar 2021 $0.4850 100.00% Interim 31 Mar 2021
    05 Mar 2020 $0.6250 100.00% Interim 27 Mar 2020
    05 Sep 2019 $0.9150 100.00% Final 30 Sep 2019
    06 Mar 2019 $0.6000 100.00% Interim 29 Mar 2019
    05 Sep 2018 $0.8650 100.00% Final 28 Sep 2018
    06 Mar 2018 $0.5750 100.00% Interim 29 Mar 2018
    05 Sep 2017 $0.0000 100.00% Final 28 Sep 2017
    07 Mar 2017 $0.5300 100.00% Interim 29 Mar 2017
    06 Sep 2016 $0.7200 100.00% Final 29 Sep 2016
    08 Mar 2016 $0.4700 100.00% Interim 30 Mar 2016
    08 Sep 2014 $0.5100 100.00% Final 24 Sep 2014
    04 Mar 2014 $0.3400 100.00% Interim 26 Mar 2014
    03 Sep 2013 $0.4150 100.00% Final 25 Sep 2013
    04 Mar 2013 $0.2900 100.00% Interim 27 Mar 2013
    05 Mar 2012 $0.2550 100.00% Interim 28 Mar 2012
    02 Sep 2011 $0.2950 100.00% Final 26 Sep 2011
    08 Mar 2011 $0.2250 100.00% Interim 28 Mar 2011
    31 Aug 2010 $0.2500 100.00% Final 27 Sep 2010
    16 Mar 2010 $0.1850 100.00% Interim 09 Apr 2010
    21 Sep 2009 $0.2150 100.00% Final 09 Oct 2009
    20 Mar 2009 $0.1650 100.00% Interim 08 Apr 2009
    25 Sep 2008 $0.1750 100.00% Final 15 Oct 2008
    26 Sep 2007 $0.1600 100.00% Final 12 Oct 2007
    27 Mar 2006 $0.1050 100.00% Interim 12 Apr 2006
    26 Sep 2005 $0.1150 100.00% Final 14 Oct 2005
    16 Apr 2004 $0.0750 100.00% Interim 30 Apr 2004

    RHC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Ramsay Health Care Ltd

    Ramsay Health Care Ltd (ASX: RHC) is one of the largest private healthcare providers in the world, with around 500 facilities across 11 countries. Its operations cover Australia, Europe, the UK, and Asia. 

    As well as private hospitals, Ramsay operates day surgeries, primary care clinics, diagnostic and imaging centres, mental health facilities, pharmacies, and an expanding range of in-home and community care services.

    It is the largest private hospital group in Australia, France, and the Scandanavian countries. Its 52.5%-owned subsidiary Ramsay Sante oversees its European operations. Its UK business includes mental health facilities and a range of clinical specialties.

    The vast majority of the company's revenue is generated from its Australian and European operations.

    RHC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    18 Nov 2026 $53.58 $-0.07 -0.13% 904,521 $53.27 $53.71 $53.01
    17 Nov 2026 $53.65 $-1.30 -2.37% 644,562 $54.53 $54.53 $52.87
    16 Nov 2026 $54.95 $-0.08 -0.15% 343,508 $54.90 $55.00 $54.25
    13 Nov 2026 $55.03 $-0.39 -0.70% 333,810 $55.26 $55.49 $54.74
    12 Nov 2026 $55.42 $-0.65 -1.16% 543,189 $56.19 $56.45 $55.42
    11 Nov 2026 $56.07 $0.13 0.23% 498,255 $55.95 $56.36 $55.72
    10 Nov 2026 $55.94 $0.45 0.81% 898,142 $55.70 $55.94 $55.14
    09 Nov 2026 $55.49 $-0.26 -0.47% 460,916 $55.65 $55.88 $55.05
    06 Nov 2026 $55.75 $-0.26 -0.46% 524,515 $55.93 $56.25 $55.50
    05 Nov 2026 $56.01 $0.76 1.38% 619,015 $56.12 $56.50 $55.27
    04 Nov 2026 $55.25 $0.03 0.05% 521,826 $55.00 $55.41 $54.65
    03 Nov 2026 $55.22 $-0.53 -0.95% 383,809 $55.65 $55.75 $54.97
    02 Nov 2026 $55.75 $0.15 0.27% 888,351 $55.60 $56.22 $55.02
    30 Oct 2026 $55.60 $0.68 1.24% 678,067 $55.40 $55.90 $55.02
    29 Oct 2026 $54.92 $-0.83 -1.49% 685,341 $55.80 $56.10 $54.69
    28 Oct 2026 $55.75 $0.20 0.36% 579,496 $55.55 $55.83 $54.74
    27 Oct 2026 $55.55 $0.61 1.11% 1,102,275 $54.72 $55.55 $54.55
    26 Oct 2026 $54.94 $0.15 0.27% 868,147 $54.24 $55.00 $53.99
    23 Oct 2026 $54.79 $-0.11 -0.20% 573,932 $55.21 $55.21 $54.53
    22 Oct 2026 $54.90 $0.65 1.20% 498,360 $54.29 $55.03 $54.11
    21 Oct 2026 $54.25 $0.15 0.28% 541,596 $54.00 $54.58 $53.66
    20 Oct 2026 $54.10 $-0.90 -1.64% 755,100 $54.51 $54.72 $53.37

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    28 Aug 2026 Michael Siddle Sell 1,000,000 $49,000,000
    Off-market trade. As per announcement on 28/08/2026
    26 Mar 2026 Steven Sargent Buy 619 $24,979
    On-market trade.
    25 Mar 2026 Craig Drummond Buy 15,000 $602,788
    On-market trade. average price per ordinary share
    24 Mar 2026 Karen Penrose Buy 701 $27,625
    On-market trade.
    15 Dec 2025 Natalie Davis Issued 74,075 $2,618,551
    Issue of securities. 131,547 Performance Rights
    26 Nov 2025 Natalie Davis Issued 21,071 $675,011
    Director remuneration. VWAP

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Ingle Thodey Non-Executive DirectorNon-Executive Chairman Nov 2017
    Mr Thodey is a business leader focused on innovation, technology, digital transformation and corporate governance. He is also Chair of Xero Limited, Chancellor the University of Sydney, co Chair of the Great Barrier Reef Foundation, a non executive member of the Reserve Bank of Australia Governance Board and the Bank of America Australia Advisory Board. He has over 40 years experience in business leadership including as CEO of Telstra and CEO of IBM Australia & New Zealand. David is active in public policy, having previously led various independent reviews including the myGov User Audit (2023) and the NSWs Government Federal Financial Relations Review (2020). He was also Chair of CSIRO (2015 to 2021) and Deputy Chair of the National COVID 19 Coordination Commission Advisory Board (2020).
    Ms Catriona Alison Deans Non-Executive Director Nov 2018
    Ms Deans has 25 years experience building technology enabled businesses involved in media, ecommerce, financial services and health, and across leadership roles as an executive, a director and in venture capital. She is also Chair of Cochlear Limited, Chair of Calix Limited and a Non Executive Director of Fitness Passport and The Observership Program. She is also a Venture Partner of Main Sequence Ventures. In her executive career, she was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas and most recently CEO of Netus Pty Ltd (a technology investment company acquired by Fairfax). She also spent seven years as a consultant with McKinsey & Company.
    Mr Michael Stanley Siddle Non-Executive Director May 1975
    Mr Siddle was re elected as a Non Executive Director in November 2023. He was Chair of the Company from 2014 to 2023, having formerly been Deputy Chairman for 17 years and a founding Director. He has built up significant knowledge of the business and the private hospital industry after starting with the Company in 1968. He has extensive experience in the management of private hospitals and has been integrally involved in Ramsay Health Cares successful expansion through developments, mergers and acquisitions. During the past three years he has not served as a director of any listed companies other than Ramsay Health Care Limited.
    Mr Craig Milton Drummond Non-Executive Director Jul 2025
    Mr Drummond was appointed as a non executive director on 1 July 2025, and brings extensive executive and board level experience across healthcare, financial services and other regulated industries. He is also Chair of Transurban Group, Chair of the Australian Foundation Investment Company Limited, Chair of the AFL Commission and Chair of The Ian Potter Foundation. He has previously served as President and Director of the Geelong Football Club Ltd, a Director of the Florey Institute of Neuroscience and Mental Health, and a Member of the Federal Governments Financial Regulator Assessment Authority. His executive career includes five years as CEO of Medibank Private Ltd (2016 to 2021). He was formerly Group Executive Finance and Strategy at National Australia Bank, and CEO and Country Head at Bank of America Merrill Lynch (Australia). Earlier in his career, Craig held senior positions at Goldman Sachs JBWere.
    Ms Helen Kurincic Non-Executive Director Mar 2024
    Ms Kurincic is an experienced director and senior executive bringing over 30 years of operational, executive and board-level experience across healthcare, specialist medicine, radiology and financial services. She is also Chair of McMillan Shakespeare and a Non Executive Director of Artrya Limited, Carlton Football Club and Carlton Imaging Pty Ltd. She was previously Chair of Integral Diagnostics and a Non Executive Director of HBF Health, Estia Health, Sirtex Medical, AMP Capital Investors Domain Principal Group, Melbourne Health, Orygen Youth Mental Health Research Centre and DCA Group. Beginning her career as an intensive care nurse, she transitioned into community health and aged care leadership and had an accomplished executive career, including as Chief Operating Officer of Genesis Care, CEO of Heart Care Victoria and CEO of Benetas.
    Ms Karen Lee Collett Penrose Non-Executive Director Mar 2020
    Ms Penrose has had an extensive executive career in leadership and CFO roles, mainly in financial services. She is well versed in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO. She has been a full-time director since 2014 and is an experienced committee chair of audit and risk. In addition to being a Non Executive Director of Ramsay, she also serves as a RHC appointee to the Board of Ramsay Generale de Sante and member of their Audit Committee. She also serves on the Boards of Bank of Queensland, Charter Hall Group and Cochlear. She is a Director of Marshall Investments Pty Limited and, in a voluntary capacity, a Director on Golf Australias Risk and Audit Committee.
    Mr Steven Andrew Sargent Non-Executive Director Nov 2021
    Mr Sargents executive career included 22 years at General Electric, where he gained extensive multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the USA, Europe and Asia Pacific. In addition to being a Non-Executive Director of Ramsay, he also serves as a Director of Ramsay Generale de Sante and is the Chair of infection prevention company Nanosonics Limited. His unlisted board activities include Chairman of The Origin Foundation Limited, Origin Energys philanthropic arm, and Non-Executive Director of The Great Barrier Reef Foundation.
    Mr Natalie Davis Chief Executive OfficerManaging Director Dec 2024
    Ms Davis joined Ramsay in October 2024 and was appointed Group CEO and Managing Director on 2 December 2024. She is also the Chair of Ramsay Generale de Sante SA. She is an accomplished senior executive and leader with extensive experience driving large scale strategic transformation, customer focus and growth. Since joining Ramsay, she has led the refresh of the Ramsay 2030 strategy, driving innovation, sustainable growth, capital discipline and a culture of performance, while embedding our purpose of people caring for people. She joined Ramsay after a decade with the Woolworths Group, where she held several roles including as Managing Director of Woolworths Supermarkets, Chief Customer Transformation Officer and Managing Director Woolworths NZ. Prior to joining Woolworths, She was a partner at McKinsey & Co, working in the Australian/New Zealand and UK offices over 15 years, serving clients on growth strategy and customer led transformation across a number of service sectors.
    Ms Henrietta Rowe Company SecretaryGroup General Counsel Jun 2019
    -
    Henrietta Rowe Company SecretaryGroup General Counsel
    -
    Anthony Neilson Group Executive Finance
    -
    Brindan Suresh Group Executive Health and Strategy
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 49,284,709 21.35%
    J P Morgan Nominees Australia Pty Limited 46,099,473 19.97%
    Netwealth Investments Limited <Wrap Services A/C> 33,484,240 14.51%
    Citicorp Nominees Pty Limited 29,804,026 12.91%
    BNP Paribas Noms Pty Ltd 6,611,597 2.86%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 6,457,173 2.80%
    Paul Ramsay Holdings Pty Limited 4,983,546 2.16%
    BNP Paribas Nominees Pty Ltd <HUB24 Custodial Serv Ltd> 3,056,111 1.32%
    Woolwich Investments Pty Ltd <The Siddle Family Trust> 2,750,000 1.19%
    Argo Investments Limited 1,907,299 0.83%
    HSBC Custody Nominees (Australia) Limited <NT Comnwlth Super Corp A/C> 1,824,045 0.79%
    BNP Paribas Noms Pty Ltd <Global Markets> 1,702,244 0.74%
    UBS Nominees Pty Ltd 810,647 0.35%
    Citicorp Nominees Pty Limited <143212 NMMT Ltd A/C> 708,145 0.31%
    Netwealth Investments Limited <Super Services A/C> 625,587 0.27%
    BNP Paribas Noms (NZ) Ltd 613,361 0.27%
    BKI Investment Company Limited 575,000 0.25%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 532,599 0.23%
    Pillar Custodial Services Pty Ltd 418,613 0.18%
    IOOF Investment Services Limited <IPS Superfund A/C> 381,311 0.17%

    Profile

    since

    Note